Dare Bioscience, Inc. (DARE) Return on equity 2021–2025
Dare Bioscience, Inc. (DARE) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-471.4%FY2025 · since FY2021: -99.8% → -471.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -471.4% | — |
| FY2022 | -278.5% | -178.7 pp |
| FY2021 | -99.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice